Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

NYSE:GCTS - New York Stock Exchange, Inc. - US36170N1072 - Common Stock - Currency: USD

2.02  -0.09 (-4.27%)

After market: 2.02 0 (0%)

Fundamental Rating

1

Overall GCTS gets a fundamental rating of 1 out of 10. We evaluated GCTS against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of GCTS have multiple concerns. GCTS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GCTS had negative earnings in the past year.
In the past year GCTS has reported a negative cash flow from operations.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

GCTS has a worse Return On Assets (-77.67%) than 92.59% of its industry peers.
Industry RankSector Rank
ROA -77.67%
ROE N/A
ROIC N/A
ROA(3y)-42.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -50 -100

1.3 Margins

GCTS has a Gross Margin of 55.11%. This is in the better half of the industry: GCTS outperforms 75.00% of its industry peers.
GCTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
GCTS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for GCTS is higher compared to a year ago.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

GCTS has an Altman-Z score of -39.05. This is a bad value and indicates that GCTS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -39.05, GCTS is not doing good in the industry: 82.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.05
ROIC/WACCN/A
WACC11.39%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.32 indicates that GCTS may have some problems paying its short term obligations.
The Current ratio of GCTS (0.32) is worse than 96.30% of its industry peers.
A Quick Ratio of 0.27 indicates that GCTS may have some problems paying its short term obligations.
GCTS has a worse Quick ratio (0.27) than 95.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.32
Quick Ratio 0.27
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

GCTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -590.69%.
EPS 1Y (TTM)-590.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 25.15% on average over the next years. This is a very strong growth
Based on estimates for the next years, GCTS will show a very strong growth in Revenue. The Revenue will grow by 85.71% on average per year.
EPS Next Y40.2%
EPS Next 2Y7.83%
EPS Next 3Y25.15%
EPS Next 5YN/A
Revenue Next Year-39.94%
Revenue Next 2Y83.29%
Revenue Next 3Y85.71%
Revenue Next 5YN/A

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GCTS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GCTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as GCTS's earnings are expected to grow with 25.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.83%
EPS Next 3Y25.15%

More info and screens

0

5. Dividend

5.1 Amount

GCTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (2/21/2025, 8:23:12 PM)

After market: 2.02 0 (0%)

2.02

-0.09 (-4.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners6.53%
Inst Owner Change8.88%
Ins Owners3.23%
Ins Owner Change6.17%
Market Cap96.43M
Analysts82.86
Price Target5.1 (152.48%)
Short Float %2.32%
Short Ratio4.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)18.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.36
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0.24
BVpS-1.22
TBVpS-1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -77.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.11%
FCFM N/A
ROA(3y)-42.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.32
Quick Ratio 0.27
Altman-Z -39.05
F-Score2
WACC11.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-590.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.34%
EPS Next Y40.2%
EPS Next 2Y7.83%
EPS Next 3Y25.15%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-39.94%
Revenue Next 2Y83.29%
Revenue Next 3Y85.71%
Revenue Next 5YN/A
EBIT growth 1Y-506.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75.44%
EBIT Next 3Y29.22%
EBIT Next 5YN/A
FCF growth 1Y-2070.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2039.15%
OCF growth 3YN/A
OCF growth 5YN/A